Inozyme Pharma, Inc. Gains 178.17%

Fri, May 16, 2025 at 06:53 PM
Inozyme Pharma, Inc. Gains 178.17%

Inozyme Pharma, Inc. (INZY:NASDAQ) soared at $3.95, a gain of 178.2%. On Fri, May 16, 2025, INZY:NASDAQ hit a New 2-Week High of $3.95. The stock got featured on our News Catalysts scanner on Fri, May 16, 2025 at 01:43 PM in the 'ACQUISITION' category. From Fri, May 02, 2025, the stock recorded 50.00% Up Days and 36.36% Green Days

About Inozyme Pharma, Inc. (INZY:NASDAQ)

Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and...

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.